One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies

BACKGROUND: Despite currently available standard-of-care inhaled corticosteroid (ICS)/long-acting β(2)-agonist therapies, a substantial proportion of patients with asthma remain inadequately controlled. This pooled analysis evaluated efficacy and safety of mometasone furoate/indacaterol acetate (MF/...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Kenneth, van Zyl-Smit, Richard, Maspero, Jorge, Kerstjens, Huib A M, Gon, Yasuhiro, Hosoe, Motoi, Tanase, Ana-Maria, Pethe, Abhijit, Shu, Xu, D’Andrea, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Asthma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404447/
https://www.ncbi.nlm.nih.gov/pubmed/34452934
http://dx.doi.org/10.1136/bmjresp-2020-000819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404447/
https://www.ncbi.nlm.nih.gov/pubmed/34452934
http://dx.doi.org/10.1136/bmjresp-2020-000819

Ejemplares similares